跳至主要内容
临床试验/NCT00855478
NCT00855478终止4 期

French Post-Marketing Surveillance Survey

Cordis Corporation0 个研究点目标入组 4,080 人开始时间: 2006年5月最近更新:
适应症

试验速览

阶段
4 期
状态
终止
入组人数
4,080
主要终点
There is no pre-specified endpoint.

研究概览

简要总结

To assess the safety and effecacy of the Cypher stent ™ & Cypher Select ™ in the normal use of medical practices, within the labeled indications.

详细描述

Multi-center, retrospective and prospective French register. This register does not impose any constraint on the evaluated population, the procedure, or the required examinations. The local practice routines should be applied.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with symptomatic ischemic heart disease due to de novo lesions (lesions <30 mm vessel reference diameter of 2.25 mm to 5 mm), assessed visually, native coronary arteries.

排除标准

  • Patients suffering from coronary heart disease.
  • Patients for whom treatment antiplatelet and / or anticoagulant is against the state;
  • Patients with injuries incompatible with the full inflation of a balloon angioplasty;
  • Transplant patients ;
  • Patients with known allergy to Sirolimus, the stainless steel 316L, to polymethacrylates or copolymers polyolefins;

结局指标

主要结局

There is no pre-specified endpoint.

时间窗: 12 Months

次要结局

未报告次要终点

研究者

申办方类型
Industry

相似试验